Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells.

Human atherosclerotic plaques contain numerous smooth muscle cells (SMCs) that express intercellular adhesion molecule-1 (ICAM-1). Expression of ICAM-1 in different cells is known to be regulated by tumor necrosis factor-alpha (TNF-alpha), which has recently been found to be present in the intimal thickening of human arteries. Therefore, we studied the effect of TNF-alpha on ICAM-1 mRNA content and surface expression in cultured human aortic SMCs by using the methods of Northern blotting and immunofluorescence flow cytometry. Under basal conditions of cultivation, ICAM-1 mRNA was not revealed in SMCs. However, treatment of the cells with recombinant human TNF-alpha induced substantial levels of ICAM-1 mRNA. The content of ICAM-1 on the surface of SMCs also increased in a dose- and time-dependent manner after incubation with TNF-alpha. Twenty-four hours of treatment with 10 ng/mL TNF-alpha led to an approximately 10-fold increase in ICAM-1 surface expression in the SMCs. Under the same conditions, pretreatment of SMCs with TNF-alpha resulted in a twofold increase of their adhesiveness for monocytes. In the presence of anti-ICAM-1 monoclonal antibody 10F3, monocyte adhesion to TNF-alpha-pretreated SMCs was significantly inhibited, suggesting that the observed monocyte-SMC interaction involved the ICAM-1 expressed on SMC surfaces as a result of TNF-alpha stimulation. These results led us to propose that TNF-alpha may act a regulator of functional ICAM-1 expression on the SMC surface and thus can increase the possibility of interactions between mononuclear cells and SMCs in atherosclerotic plaques.

[1]  G. Hansson,et al.  Adhesion of Activated T Lymphocytes to Vascular Smooth Muscle Cells and Dermal Fibroblasts is Mediated by β1‐ and β2‐Integrins , 1992 .

[2]  R. Wallace,et al.  Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. , 1992, The Journal of biological chemistry.

[3]  A. Gown,et al.  Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. , 1992, The American journal of pathology.

[4]  A. Gown,et al.  A 90-kDa surface antigen of immature smooth muscle cells is ICAM-1. , 1991, The American journal of physiology.

[5]  H. Rus,et al.  Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. , 1991, Atherosclerosis.

[6]  G. Canonica,et al.  Expression of intercellular adhesion molecule‐1 (ICAM‐1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer , 1991, Clinical and experimental immunology.

[7]  D. Brennan,et al.  Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1. , 1990, Kidney international.

[8]  J. Macartney,et al.  Differential upregulation of intercellular adhesion molecule‐1 in coeliac disease , 1990, Clinical and experimental immunology.

[9]  J. Thyberg,et al.  Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.

[10]  S M Schwartz,et al.  Developmental mechanisms underlying pathology of arteries. , 1990, Physiological reviews.

[11]  L. Glimcher,et al.  Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. , 1990, Kidney international.

[12]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[13]  J. Korn,et al.  ICAM-1-dependent fibroblast-lymphocyte adhesion: discordance between surface expression and function of ICAM-1. , 1990, Cellular immunology.

[14]  L. Osborn,et al.  Leukocyte adhesion to endothelium in inflammation , 1990, Cell.

[15]  J. J. van den Oord,et al.  Hepatic expression of intercellular adhesion molecule‐1 (ICAM‐1) in viral hepatitis B , 1990, Hepatology.

[16]  R. Sobel,et al.  Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. , 1990, The American journal of pathology.

[17]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.

[18]  R. Rothlein,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.

[19]  P. Libby,et al.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. , 1989, Journal of immunology.

[20]  A. Desmoulière,et al.  Detection of atherosclerotic plaque with two monoclonal antibodies. 2P1A2 monoclonal antibody is specific for smooth muscle cells in atherosclerotic plaque. , 1988, Atherosclerosis.

[21]  Michael Loran Dustin,et al.  Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells , 1988, The Journal of cell biology.

[22]  T. Springer,et al.  Functional evidence that intercellular adhesion molecule‐1 (icam‐1) is a ligand for lfa‐1d‐ependent adhesion in t cell‐mediated cytotoxicity , 1988, European journal of immunology.

[23]  Michael Loran Dustin,et al.  Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1) , 1988, The Journal of experimental medicine.

[24]  Michael Loran Dustin,et al.  Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families , 1988, Cell.

[25]  B. Seed,et al.  ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM , 1988, Nature.

[26]  E. Emeson,et al.  T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. , 1988, The American journal of pathology.

[27]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[28]  Timothy A. Springer,et al.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) , 1987, Cell.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[30]  C. Haslett,et al.  Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium. , 1987, Journal of immunology.

[31]  R. Coleman,et al.  In vitro function of indium-111 oxine-labeled human monocytes. , 1986, Journal of immunological methods.

[32]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.

[33]  W. Fiers,et al.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. , 1986, Journal of immunology.

[34]  Michael Loran Dustin,et al.  A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. , 1986, Journal of immunology.

[35]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.

[36]  S. Schwartz,et al.  Replication of smooth muscle cells in vascular disease. , 1986, Circulation research.

[37]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[38]  N. Pawlowski,et al.  Human monocyte-endothelial cell interaction in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Waldmann,et al.  Monocytic origin of foam cells in human atherosclerotic plaques. , 1984, Atherosclerosis.

[40]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[41]  N. Young,et al.  An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. , 1972, The Journal of clinical investigation.

[42]  W. Crosby,et al.  Cytochemical identification of monocytes and granulocytes. , 1971, American journal of clinical pathology.

[43]  G. Haines,et al.  Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[44]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[45]  G. Riethmüller,et al.  De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  B. Beutler,et al.  The biology of cachectin/TNF--a primary mediator of the host response. , 1989, Annual review of immunology.

[47]  A. Faerman,et al.  A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions. , 1989, The American journal of pathology.

[48]  E. Hersh,et al.  Centrifugal elutriation as a method for isolation of large numbers of functionally intact human peripheral blood monocytes , 1986, Journal of clinical apheresis.

[49]  E. Jaffe Culture and identification of large vessel endothelial cells , 1984 .

[50]  J. Thyberg,et al.  Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. , 1983, Differentiation; research in biological diversity.